Voyageur Pharmaceuticals Ratios and Metrics

Market cap in millions CAD. Fiscal year is December - November.

Millions CAD. Fiscal year is Dec - Nov.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 10, 2026	Nov '25 Nov 30, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021
Market Cap	35	29	9	5	8	9
Market Cap Growth	26.37%	215.19%	70.79%	-34.31%	-11.82%	221.01%
Enterprise Value	34.68	28.35	8.94	5.35	8.07	8.39
Last Close Price	0.17	0.16	0.07	0.04	0.07	0.09
PS Ratio	742.67	2445.35	-	-	-	-
PB Ratio	85.94	22.81	20.15	3.70	5.52	4.81
P/TBV Ratio	71.11	21.16	19.88	3.64	5.15	4.47
EV/Sales Ratio	-	2425.92	-	-	-	-
Debt / Equity Ratio	0.10	0.03	0.09	0.03	0.02	0.01
Net Debt / Equity Ratio	-0.98	-0.18	-0.28	0.03	0.00	-0.40
Net Debt / EBITDA Ratio	0.10	0.06	0.07	-0.03	0.00	0.38
Net Debt / FCF Ratio	0.40	0.08	0.42	-0.04	0.00	0.46
Asset Turnover	0.01	0.00	0	0	0	0
Inventory Turnover	0.55	0.20	0	0	0	0
Quick Ratio	0.18	0.22	0.10	0.06	0.09	1.38
Current Ratio	0.23	0.33	0.17	0.13	0.27	1.43
Return on Equity (ROE)	-457.07%	-415.01%	-181.07%	-96.50%	-104.07%	-185.44%
Return on Assets (ROA)	-123.57%	-123.87%	-71.70%	-65.72%	-75.42%	-106.79%
Return on Invested Capital (ROIC)	-152.53%	-148.79%	-79.13%	-69.74%	-96.75%	-129.45%
Return on Capital Employed (ROCE)	-459.39%	-393.29%	-171.26%	-93.49%	-101.93%	-177.57%
Buyback Yield / Dilution	-18.11%	-20.37%	-5.46%	-21.03%	-13.89%	-34.24%
Total Shareholder Return	-18.11%	-20.37%	-5.46%	-21.03%	-13.89%	-34.24%